I70.713 Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs

Name of the Condition

• Common Name: Bilateral Leg Bypass Graft Atherosclerosis with Claudication
• Medical Term: Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs
• ICD-10 Code: I70.713

Summary

Atherosclerosis of other type of bypass graft(s) of the extremities with intermittent claudication, bilateral legs, refers to plaque buildup in bypass grafts used to restore blood flow to both legs, causing reduced blood flow and leg pain during activity. This condition narrows the graft, potentially leading to complications like graft failure or limb ischemia.

Causes

Atherosclerosis in bypass grafts develops due to the accumulation of fatty deposits, cholesterol, and other substances within the graft walls. This process is often accelerated by factors like poor blood flow, graft material, or underlying vascular disease, leading to narrowing and reduced graft function over time.

Risk Factors

• Age (more common in older adults)
• History of atherosclerosis or vascular disease
• Smoking or tobacco use
• Diabetes
• Hypertension (high blood pressure)
• High cholesterol or triglyceride levels
• Sedentary lifestyle
• Obesity

Symptoms

• Leg pain during activity (claudication) in both legs
• Reduced pulse or blood flow in both legs
• Skin changes (pale, cool, or shiny skin)
• Non-healing wounds or ulcers
• Numbness or weakness in the extremities
• Graft-related complications (e.g., infection, thrombosis)

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and diagnostic tests. Physical examination may reveal reduced pulses, skin changes, or wounds. Non-invasive tests like ankle-brachial index (ABI) or Doppler ultrasound assess blood flow. Imaging studies such as angiography or CT angiography may visualize graft narrowing or blockages. Laboratory tests may evaluate cholesterol, glucose, or inflammatory markers.

Treatment Options

Treatment focuses on managing symptoms, improving blood flow, and preventing complications. Lifestyle modifications include smoking cessation, regular exercise, and a heart-healthy diet. Medications may include antiplatelet agents, statins, or blood pressure control. Revascularization procedures, such as angioplasty, stenting, or graft revision, may be necessary for severe cases. In some instances, surgical bypass or amputation may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of graft narrowing, overall vascular health, and response to treatment. Regular follow-up is essential to monitor graft function, adjust medications, and address complications. Lifestyle changes and adherence to treatment plans improve outcomes. Early intervention reduces the risk of limb loss or graft failure.

Complications

Potential complications include graft thrombosis (blockage), graft infection, limb ischemia, non-healing ulcers, or amputation. Untreated, the condition may progress to chronic limb-threatening ischemia or require surgical intervention.

Lifestyle & Prevention

• Quit smoking or avoid tobacco use
• Maintain a balanced diet low in saturated fats and cholesterol
• Engage in regular physical activity (e.g., walking) to improve circulation
• Manage diabetes, hypertension, and cholesterol levels
• Monitor for signs of reduced blood flow or skin changes
• Follow up with healthcare providers for routine vascular assessments

When to Seek Professional Help

Seek medical attention if you experience persistent leg pain during activity, non-healing wounds, skin discoloration, or sudden changes in limb temperature or sensation. Prompt evaluation is critical to prevent complications like graft failure or limb loss.

Tips for Medical Coders

Document the bilateral nature of the condition and intermittent claudication to support code I70.713. Include details about bypass graft type, location, and clinical findings (e.g., claudication) to ensure accurate coding. Verify that documentation aligns with the specific code requirements for bilateral involvement and symptom presentation.